Viewing Study NCT03127618


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2025-12-26 @ 3:43 AM
Study NCT ID: NCT03127618
Status: APPROVED_FOR_MARKETING
Last Update Posted: 2020-05-15
First Post: 2017-04-20
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Lorlatinib - PF-06463922
Sponsor: Pfizer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Design Module Arms Interventions Module Eligibility Module